Merck Life Science A/S: Financial statements 2022
CVR: 20830131
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,256,087,140 and a net result of DKK 46,001,362 compared with DKK 37,723,717 the year before. That is an increase of 24.5% compared with the year before. The profit margin was 3.7%. Equity in the 2022 report amounted to DKK 166,245,490. The solvency ratio was 71.3%. The company had 20 employees in the financial year.
- Revenue
- DKK 1,256,087,140
- Gross Profit
- DKK 80,125,077
- Profit/Loss
- DKK 46,001,362
- Equity
- DKK 166,245,490
- Total Assets
- DKK 233,185,876
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 1.3B | 80.1M | 46M | 166.2M | 20 |
| 2021 | 1B | 69.8M | 37.7M | 214.7M | 16 |
| 2020 | 768.2M | 72.1M | 41.3M | 177M | 16 |
| 2019 | - | 53.4M | 27.4M | 135.7M | 9 |
| 2018 | - | 26.9M | 16.7M | 67.1M | 14 |
Official annual report
Keep an eye on Merck Life Science A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 1, 2022, Montserrat Jansa Rodriguez has joined the board of directors of Merck Life Science A/S.
As of October 1, 2022, Montserrat Jansa Rodriguez is registered as adm. dir. of Merck Life Science A/S.
As of September 30, 2022, Enrique Álvarez Fernández has left the board of directors of Merck Life Science A/S.
As of September 30, 2022, Enrique Álvarez Fernández has stepped down as adm. dir. of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2021. Revenue came to DKK 1,008,595,819, and the net result was DKK 37,723,717.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.
